Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1
- PMID: 15895080
- DOI: 10.1038/ng1566
Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1
Abstract
Acquired mutations in the hematopoietic transcription factor GATA binding protein-1 (GATA1) are found in megakaryoblasts from nearly all individuals with Down syndrome with transient myeloproliferative disorder (TMD, also called transient leukemia) and the related acute megakaryoblastic leukemia (DS-AMKL, also called DS-AML M7). These mutations lead to production of a variant GATA1 protein (GATA1s) that is truncated at its N terminus. To understand the biological properties of GATA1s and its relation to DS-AMKL and TMD, we used gene targeting to generate Gata1 alleles that express GATA1s in mice. We show that the dominant action of GATA1s leads to hyperproliferation of a unique, previously unrecognized yolk sac and fetal liver progenitor, which we propose accounts for the transient nature of TMD and the restriction of DS-AMKL to infants. Our observations raise the possibility that the target cells in other leukemias of infancy and early childhood are distinct from those in adult leukemias and underscore the interplay between specific oncoproteins and potential target cells.
Similar articles
-
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.Nat Genet. 2002 Sep;32(1):148-52. doi: 10.1038/ng955. Epub 2002 Aug 12. Nat Genet. 2002. PMID: 12172547
-
Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.Br J Haematol. 2009 Oct;147(1):3-12. doi: 10.1111/j.1365-2141.2009.07789.x. Epub 2009 Jul 6. Br J Haematol. 2009. PMID: 19594743 Review.
-
GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.Br J Haematol. 2005 Feb;128(4):548-51. doi: 10.1111/j.1365-2141.2004.05342.x. Br J Haematol. 2005. PMID: 15686466
-
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.Blood. 2003 Aug 1;102(3):981-6. doi: 10.1182/blood-2002-11-3599. Epub 2003 Mar 20. Blood. 2003. PMID: 12649131
-
Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.Pediatr Blood Cancer. 2005 Jan;44(1):85-91. doi: 10.1002/pbc.20161. Pediatr Blood Cancer. 2005. PMID: 15390279 Review.
Cited by
-
Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view.Expert Rev Mol Med. 2021 Apr 27;23:e5. doi: 10.1017/erm.2021.6. Expert Rev Mol Med. 2021. PMID: 33902785 Free PMC article.
-
Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.Blood. 2013 Aug 8;122(6):988-98. doi: 10.1182/blood-2012-10-460998. Epub 2013 May 29. Blood. 2013. PMID: 23719302 Free PMC article.
-
Myeloid leukemia in Down syndrome.Crit Rev Oncog. 2011;16(1-2):25-36. doi: 10.1615/critrevoncog.v16.i1-2.40. Crit Rev Oncog. 2011. PMID: 22150305 Free PMC article. Review.
-
Prenatal diagnosis of Down syndrome combined with transient abnormal myelopoiesis in foetuses with a GATA1 gene variant: two case reports.Mol Cytogenet. 2023 Oct 19;16(1):27. doi: 10.1186/s13039-023-00658-w. Mol Cytogenet. 2023. PMID: 37858167 Free PMC article.
-
Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models.Blood Adv. 2018 Jul 10;2(13):1616-1627. doi: 10.1182/bloodadvances.2018016089. Blood Adv. 2018. PMID: 29986854 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
